Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOTAMIR: 68Ga-DOTATOC PET Imaging in Myocarditis
NCT03347760Completed
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Jul 2020
- Primary completion
- Jul 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of gallium Ga 68-edotreotide in myocarditis, sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Presence of a significant myocardial retention of 68Ga-DOTATOC during initial staging. Started Jul 2020; status: completed.
02
Drugs
gallium Ga 68-edotreotide
03
Conditions
myocarditis
Beyond the preview
Go deeper on NCT03347760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03347760.